CureVac Development Diligence Sample Clauses
The CureVac Development Diligence clause requires CureVac to use a specified level of effort and resources to advance the development of a product or technology under the agreement. Typically, this means CureVac must meet certain milestones, adhere to timelines, or follow industry standards in research and development activities. This clause ensures that CureVac remains committed to progressing the project efficiently, thereby protecting the interests of the other party and reducing the risk of unnecessary delays or lack of progress.
CureVac Development Diligence. Subject to GSK complying with its obligations under this Agreement, CureVac will conduct all Development activities assigned to it the R&D Plans in a timely manner and in accordance with the R&D Plan, and obtain and maintain sufficient facilities, personnel (with appropriate qualifications and experience), equipment, materials and other resources as are reasonable and adequate to complete the R&D Plans.